Welcome to the August Issue of GEMS!

    As India proudly celebrates its 79th Independence Day, this edition of GEMS draws a deeper connection between national freedom and individual health empowerment. For millions living with diabetes, true independence means more than medical stability—it means living without limitations, without the constant fear of complications, and with the full confidence to thrive. This month, we highlight bold scientific strides, clinical innovations, and public health insights that are helping redefine what independence means for people with diabetes.

    We begin with a groundbreaking study from Vietnam that sheds light on what people living with type 2 diabetes (T2D) truly value in their healthcare journey. The study found that nearly half of the participants preferred counseling on nutrition and lifestyle over other topics—highlighting the importance of personalized education in promoting better self-management and long-term outcomes.

    In our lead feature, we spotlight cutting-edge immunotherapy research where scientists have successfully used stem cell–derived regulatory T cells to retrain the immune system—offering a potentially transformative solution for halting the autoimmune destruction seen in type 1 diabetes. Meanwhile, a new digital care model is breaking access barriers—CGM-enhanced eConsults are bringing endocrinology-level expertise into primary care settings, significantly improving outcomes for underserved patients and underscoring the power of virtual care to drive equity.

    On the prevention front, research into maternal diet and its impact on type 1 diabetes risk in children reveals how early inflammation—driven by poor prenatal nutrition—can increase autoimmune risk in offspring. The findings emphasize that the roots of chronic disease can begin far earlier than we once thought, making a strong case for upstream, lifecycle-focused interventions.

    From an epidemiological lens, we feature a pivotal study highlighting how continuous glucose monitoring (CGM) metrics—especially time-in-range and glycemic variability—are powerful predictors of long-term mortality in diabetes. These insights are shaping a more personalized and proactive approach to care, moving beyond HbA1c alone.

    In our lifestyle section, a compelling study unpacks the association between different forms of potato consumption and diabetes risk. Notably, French fries were linked to a significantly higher risk of type 2 diabetes, while boiled or baked potatoes appeared neutral. Swapping starchy choices with whole grains emerged as a protective strategy—reminding us that food choices matter just as much as food groups.

    To complement this science with simplicity, our GEMS Recipe of the Month brings you Ranch-Roasted Chickpeas—a crunchy, satisfying, and blood sugar-friendly snack perfect for the rainy season. It’s a great reminder that healthy eating can be both delicious and diabetes-conscious.

    This month’s Drug Update covers the FDA’s approval of Wegovy® (semaglutide) for the treatment of noncirrhotic MASH (Metabolic dysfunction-associated steatohepatitis) with moderate to advanced fibrosis. This landmark approval marks the first pharmacologic treatment for this serious liver-metabolic condition and reinforces the shared pathophysiology between obesity, diabetes, and liver disease.

    In this issue, we spotlight a groundbreaking Device Update: the FDA’s first-ever clearance of an over-the-counter continuous glucose monitoring (CGM) system for weight management. Developed by Signos and powered by Dexcom’s Stelo sensor, this innovative

    Finally, don’t miss our Picture of the Month and video of the month. In our Picture of the Month, we feature a CGM graph illustrating the Somogyi Effect, a critical phenomenon where nocturnal hypoglycemia triggers rebound hyperglycemia. Understanding this pattern is essential for fine-tuning insulin regimens and avoiding overtreatment.

    Our Video of the Month features an insightful explanation by Dr. Jothydev Kesavadev, detailing the essential differences between the new Libre 2 Plus CGM and earlier CGM models. If you're curious about how next-gen technology enhances real-time diabetes management, this video is a must-watch.

    This Independence Day, GEMS celebrates the expanding frontier of diabetes care that not only treats but empowers. As we honor the freedom of our nation, let us also advance the freedom of health, choice, and opportunity for every individual living with diabetes.

    Wishing you an inspiring month ahead.

To visit our previous issues, click here

Thanking you once again for the comments and suggestions. If in case you are not interested in receiving this free monthly scientific newsletter, kindly reply with "delete gems" in the subject line to info@jothydev.net

Regards

JDC Diabetes Gems Team
Jothydev's Diabetes and Research Centres
Trivandrum, Attingal and Kochi, Kerala, INDIA
+91 9846040055, +91 9562040055 , +91 9746366655
http://www.jothydev.net